Marrow stromal cell transplantation in stroke and traumatic brain injury - PubMed (original) (raw)
Review
Marrow stromal cell transplantation in stroke and traumatic brain injury
Yi Li et al. Neurosci Lett. 2009.
Abstract
There is a paucity of therapies for most central nervous system (CNS) disorders. Bone marrow stromal cells (MSCs) are a mixed cell population, including stem and progenitor cells, and are currently a strong candidate for cell-based therapy in "brain attack", including stroke, and traumatic brain injury (TBI), since they are easily isolated and can be expanded in culture from patients without ethical and technical problems. Although it has been suggested that trans-differentiation of MSCs into cells of neural lineage may occur in vitro, no one has yet observed that MSCs give rise to fully differentiated and functional neurons in vivo. The overwhelming body of data indicate that bioactive factors secreted by MSCs in response to the local environment underlie the tissue restorative effects of MSCs. The MSCs that are employed in this therapy are not necessarily stem cells, but progenitor and differentiated cells that escape immune system surveillance and survive in the CNS even for transplantation of allogeneic or xenogeneic MSCs. The injured CNS is stimulated by the MSCs to amplify its intrinsic restorative processes. Treatment of damaged brain with MSCs promotes functional recovery, and facilitates CNS endogenous plasticity and remodeling. The current mini-review is mainly based on our data and focuses on possible cellular and molecular mechanisms of interaction of MSCs with glia, neurons and vessels after brain attack. The transplantation of MSCs opens up new avenues of cell therapy and may provide an effective treatment for various CNS diseases.
Similar articles
- Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury.
Parr AM, Tator CH, Keating A. Parr AM, et al. Bone Marrow Transplant. 2007 Oct;40(7):609-19. doi: 10.1038/sj.bmt.1705757. Epub 2007 Jul 2. Bone Marrow Transplant. 2007. PMID: 17603514 Review. - Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain.
Mahmood A, Lu D, Chopp M. Mahmood A, et al. Neurosurgery. 2004 Nov;55(5):1185-93. doi: 10.1227/01.neu.0000141042.14476.3c. Neurosurgery. 2004. PMID: 15509325 - Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors.
Chen Q, Long Y, Yuan X, Zou L, Sun J, Chen S, Perez-Polo JR, Yang K. Chen Q, et al. J Neurosci Res. 2005 Jun 1;80(5):611-9. doi: 10.1002/jnr.20494. J Neurosci Res. 2005. PMID: 15880454 - Bone marrow stromal cells in traumatic brain injury (TBI) therapy: true perspective or false hope?
Opydo-Chanek M. Opydo-Chanek M. Acta Neurobiol Exp (Wars). 2007;67(2):187-95. doi: 10.55782/ane-2007-1647. Acta Neurobiol Exp (Wars). 2007. PMID: 17691227 Review.
Cited by
- Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage.
Hazell AS. Hazell AS. Neurochem Res. 2024 Jun;49(6):1450-1467. doi: 10.1007/s11064-024-04137-5. Epub 2024 May 9. Neurochem Res. 2024. PMID: 38720090 Review. - Mesenchymal stem cells reduce long-term cognitive deficits and attenuate myelin disintegration and microglia activation following repetitive traumatic brain injury.
Wang LW, Chio CC, Chao CM, Chao PY, Lin MT, Chang CP, Lin HJ. Wang LW, et al. Sci Prog. 2024 Jan-Mar;107(1):368504241231154. doi: 10.1177/00368504241231154. Sci Prog. 2024. PMID: 38425276 Free PMC article. - Role of exosomal ncRNAs in traumatic brain injury.
Beylerli O, Tamrazov R, Gareev I, Ilyasova T, Shumadalova A, Bai Y, Yang B. Beylerli O, et al. Noncoding RNA Res. 2023 Oct 12;8(4):686-692. doi: 10.1016/j.ncrna.2023.10.004. eCollection 2023 Dec. Noncoding RNA Res. 2023. PMID: 37860267 Free PMC article. Review. - Use of Cells, Supplements, and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update.
Garcia E, Buzoianu-Anguiano V, Silva-Garcia R, Esparza-Salazar F, Arriero-Cabañero A, Escandon A, Doncel-Pérez E, Ibarra A. Garcia E, et al. Int J Mol Sci. 2023 Sep 11;24(18):13946. doi: 10.3390/ijms241813946. Int J Mol Sci. 2023. PMID: 37762251 Free PMC article. Review. - Clinical experience: Outcomes of mesenchymal stem cell transplantation in five stroke patients.
Ercelen N, Karasu N, Kahyaoglu B, Cerezci O, Akduman RC, Ercelen D, Erturk G, Gulay G, Alpaydin N, Boyraz G, Monteleone B, Kural Z, Silek H, Temur S, Bingol CA. Ercelen N, et al. Front Med (Lausanne). 2023 Jan 19;10:1051831. doi: 10.3389/fmed.2023.1051831. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744151 Free PMC article.
References
- Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the adult brain. Neuron. 2004;41:683–686. - PubMed
- Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874–882. - PubMed
- Chari DM, Blakemore WF. Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia. 2002;37:307–313. - PubMed
- Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res. 2003;73:778–786. - PubMed
- Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci. 2001;189:49–57. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical